De oftest rapporterede bivirkninger ved behandlingen med azacitidin var hæmatologiske (71, 4%), herunder trombocytopeni, neutropeni og leukopeni (oftest grad 3- 4), symptomer fra mave- tarmkanalen (60, 6%), herunder kvalme og opkastning (oftest grad 1- 2) eller reaktioner på injektionsstedet (77, 1%; oftest grad 1- 2).
5 The most commonly reported adverse reactions with azacitidine treatment were haematological reactions (71.4%) including thrombocytopenia, neutropenia and leukopenia (usually Grade 3-4), gastrointestinal events (60.6%) including nausea, vomiting (usually Grade 1-2) or injection site reactions (77.1%; usually Grade 1-2).